Main Sequence Ventures

Egypt
Main Sequence Ventures invests in ambitious founders creating the next set of global industries leveraging deep tech or frontier technologies. The firm is backed by the Australian National Science Agency, CSIRO, the Australian Federal Government, and private investors. All Main Sequence investments leverage world-leading research from Australianpublic research organizations such as CSIRO, any of Australia's 41 universities or its multitude of other industry research agencies.
Founded:2017
Firm Location:Egypt • Melbourne, Australia • Sydney, Australia • Australia
Main Sequence Ventures Team
Photo of Alezeia Brown, Principal at Main Sequence Ventures
Alezeia Brown
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Australia
Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Space (Series A), Investors in Space (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Martin Duursma, Partner at Main Sequence Ventures
Martin Duursma
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Sydney (Australia)
Investors in EnergyTech (Series B), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in Space (Series B), Investors in Space (Series A), Investors in Space (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Mohamed Fahmy, Managing Partner at Main Sequence Ventures
Mohamed Fahmy
Main Sequence Ventures·Managing Partner
Sweet spot: $9.5M
Range: $8.0M - $11.0M
Investors in Egypt
Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Phil Morle, Partner at Main Sequence Ventures
Phil Morle
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Sydney (Australia)
Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Danielle Haj Moussa, Analyst at Main Sequence Ventures
Danielle Haj Moussa
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Sydney (Australia)
Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Gabrielle Munzer, Partner at Main Sequence Ventures
Gabrielle Munzer
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Melbourne (Australia)
Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Pre-seed)
Photo of Jun Qu, Principal at Main Sequence Ventures
Jun Qu
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Sydney (Australia)
Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Series A), Investors in Space (Series A), Investors in Space (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Alejandra Romero, Analyst at Main Sequence Ventures
Alejandra Romero
Sweet spot: $10.1M
Range: $250K - $20.0M
Investors in Sydney (Australia)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed)
Photo of Mike Zimmerman, Partner at Main Sequence Ventures
Mike Zimmerman
Sweet spot: $3.0M
Range: $250K - $10.0M
Investors in Australia